UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000025156 |
|---|---|
| Receipt number | R000028938 |
| Scientific Title | Randomized Phase II Study on the Additive Effect of Everolimus in Post-Menopausal Patients with Endocrine Therapy-Sensitive ER-Positive HER2-Negative Metastatic Breast Cancer |
| Date of disclosure of the study information | 2017/03/01 |
| Last modified on | 2017/04/26 16:57:40 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/12/06 17:01:12 | ||
| 2 | Update | 2017/03/09 18:27:50 | Acronym |
|
| 3 | Update | 2017/03/09 18:32:16 | Last name of contact person Last name of contact person Division name Division name Homepage URL Organization Category of Funding Organization |
|
| 4 | Update | 2017/03/09 18:33:11 | Date of protocol fixation Anticipated trial start date |
|
| 5 | Update | 2017/04/25 19:51:04 | Organization Organization Category of Funding Organization |
|
| 6 | Update | 2017/04/26 16:57:40 | Recruitment status |
